The largest database of trusted experimental protocols

Mycoalert mycoplasma detection kit

Manufactured by Cambrex
Sourced in United States

The MycoAlert Mycoplasma Detection Kit is a biochemical test kit designed to detect the presence of mycoplasma contamination in cell culture samples. The kit utilizes a bioluminescent assay to quantify the activity of mycoplasma-specific enzymes, providing a rapid and sensitive method for mycoplasma detection.

Automatically generated - may contain errors

13 protocols using mycoalert mycoplasma detection kit

1

Cultivation of Human Cell Lines and Viral Propagation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human fetal lung fibroblasts (MRC5) were purchased from ATCC and umbilical vein cells (HUVECs) were either freshly isolated from donors or purchased from Clonetics, Lonza respectively. The MRC5 were grown in minimum essential medium (MEM, Invitrogen) supplemented with glutamine, 10% fetal bovine serum (FBS) and standard Penicillin and Streptomycin (PS). The HUVEC were cultured in EBM-2 endothelial basal medium supplemented with the EGM-2 Single Quots (Clonetics, Lonza). NIH/3T3 mouse embryonic fibroblast cells were purchased from ATCC and they were cultured in Dulbecco’s Modified Eagle’s medium (DMEM, Invitrogen) supplemented with 10% fetal bovine serum (FBS) and standard Penicillin and Streptomycin (PS). MycoAlert mycoplasma detection kit (Clonetics, Lonza) was used to verify that cells were mycoplasma-free. The HCMV clinical strain VR1814 (a kind gift from Dr Giuseppe Gerna, University of Pavia, Italy), the HSV-1 (a kind offer from Prof. Maria Masucci’s lab, Karolinska Institute, Sweden), and the MCMV Smith strain (kindly provided by Dr. Frank Stassen, University of Maastricht, Netherlands) were used for the study. The VR1814 virus was propagated in HUVECs and titrated [60 (link)] in MRC5 fibroblasts (ATCC), and frozen at -80°C.
+ Open protocol
+ Expand
2

Standardized Propagation of Human Cytomegalovirus

Check if the same lab product or an alternative is used in the 5 most similar protocols
The viral stock was a plaque-purified clinical isolate, VR 1814, from cervical secretions (a kind gift from Dr. Giuseppe Gerna, University of Pavia, Italy). The virus was propagated in human umbilical vein cells (HUVECs) [Clonetics, Lonza; or isolated from donors as described [25 (link)], titrated in MRC-5 fibroblasts (ATCC), aliquoted, and frozen at −80°C as described [6 (link)]. Alternatively, the virus was further passaged once in MRC-5 cells, which was subjected to a freeze-thaw cycle; the cellular materials were clarified and ultracentrifuged at 28,000 rpm for 1h at 4°C (Beckman, Optima L-90K Ultracentrifugation). The viral pellet was resuspended in 0.1 M sucrose-phosphate buffer to increase the viral titer as described [26 (link)]. The GBM cell lines U-373 MG (Uppsala), U-251 MG, and U-343 MGa (a kind gift from Dr. M. Nister, Karolinska Institutet, Stockholm, Sweden) were used for in vitro experiments. The growth medium for HUVECs or MRC-5 was as described before [6 (link)]. All GBM cell lines were grown in RPMI supplemented with 10% fetal bovine serum, 100 U/ml of penicillin, 100 μg/ml streptomycin, and 5 μg/ml plasmocin (InvivoGen). All cells were maintained in a humidified 5% CO2 incubator and verified as mycoplasma-free with the MycoAlert mycoplasma detection kit (Clonetics, Lonza).
+ Open protocol
+ Expand
3

Mycoplasma Detection in Viral Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mycoplasma detection was performed on the last harvest of viral vector stocks derived from the 293Vec and the PG13 packaging cell lines in the test runs performed with the iCELLis Nano 200 mL C1 bioreactors using the MycoAlert Mycoplasma Detection Kit, following manufacturer’s recommendations (Cambrex).
+ Open protocol
+ Expand
4

Culture of Liposarcoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human liposarcoma cell lines SW872 (an undifferentiated liposarcoma, ATCC catalog number: HTB-92) and SW982 (another undifferentiated liposarcoma as evaluated by histopathology, ATCC catalog number: HTB-93) were purchased from the ATCC (Rockville, MD). These cell lines were cultured in RPMI 1640 (Invitrogen, Carlsbad, CA) supplemented with 10% FBS, 100 units/ml penicillin and 100 μg/ml streptomycin (Invitrogen). Cells were incubated at 37°C in a 5% CO2-95% air atmosphere and passaged when near confluent monolayers were achieved using Trypsin-EDTA solution. Cells were free of Mycoplasma contamination, as tested by the MycoAlert Mycoplasma Detection Kit from Cambrex (Rockland, ME).
+ Open protocol
+ Expand
5

Mycoplasma Detection in Viral Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mycoplasma detection was performed on the last harvest of viral vector stocks derived from the 293Vec and the PG13 packaging cell lines in the test runs performed with the iCELLis Nano 200mL C1 bioreactors using the MycoAlert Mycoplasma Detection Kit, following manufacturer's recommendations (Cambrex). The level of sensitivity is between 0.1 and 10EU/mL.
+ Open protocol
+ Expand
6

Comprehensive Cell Line Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human A375P (CRL-3224), DLD-1 (CCL-221), MIA PaCa-2 (CRL-1420) and A549 (CCL-185), and mouse B16-F10 (CRL-6475) cell lines were purchased from American Tissue Type Collection (ATCC). The human melanoma PDX lines WM4380 and WM4552 were obtained from Meenhard Herlyn, Wistar Institute. All cell lines were tested for Mycoplasma biannually by MycoAlert Mycoplasma Detection Kit (Cambrex Bio Science Rockland, Inc.), and authenticated using short-tandem repeat fingerprinting by University of Pennsylvania Core facilities. The A375P cell line was cultured in RPMI 1640 (Invitrogen, 11875), and other cell lines were cultured in DMEM, supplemented with 10 % fetal bovine serum (F6178, Sigma-Aldrich) and 1X antibiotic antimycotic solution (A5955, Sigma-Aldrich). Cells were grown at 37°C in the presence of 5 % CO2.
+ Open protocol
+ Expand
7

Establishing Multidrug Resistant Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The multidrug resistant U-2OSMR (established by selection against doxorubicin) and U-2OSTR (established by selection against taxol/paclitaxel) was established in our laboratory as previously reported [20 (link), 23 (link)]. The multidrug resistant KHOSR2 (established by selection with doxorubicin) cell line was kindly provided by Dr. Efstathios Gonos (Institute of Biological Research and Biotechnology, Athens, Greece) [29 (link)]. These cell lines were cultured in RPMI 1640 (Invitrogen, CA) supplemented with 10% FBS, 100 units/mL penicillin, and 100 μg/mL streptomycin (Invitrogen). Cells were incubated at 37°C in 5% CO2-95% air atmosphere and passaged when near-confluent monolayers were achieved using trypsin-EDTA solution. Drug resistant cell lines were periodically cultured in the respective drug to confirm their drug resistance characteristics. Cells were free from Mycoplasma contamination as tested using the MycoAlert Mycoplasma Detection Kit from Cambrex (East Rutherford, NJ).
+ Open protocol
+ Expand
8

Characterization of Osteosarcoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human osteosarcoma cell lines U-2OS and KHOS were purchased from the American Type Tissue Collection (Rockville, MD). Dr. Efstathios S. Gonos (National Health Research Foundation, Athens, Greece) kindly provided the human osteosarcoma multidrug resistant cell lines KHOSR2 and U-2OSR2 [13 (link),14 (link)]. All cell lines were cultured in RPMI 1640 (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum, 100-units/ml penicillin, and 100µg/ml streptomycin (Invitrogen). Cells were incubated at 37°C in 5% CO2-95% air atmosphere and passaged when near confluent monolayers were achieved using 2% trypsin-EDTA solution. Doxorubicin, cisplatin, and Taxol (paclitaxel) were obtained as unused residual clinical material at the Massachusetts General Hospital. Cells were free of mycoplasma contamination as tested by MycoAlert ® Mycoplasma Detection Kit from Cambrex (Rockland, ME).
+ Open protocol
+ Expand
9

Ovarian Cancer Cell Line Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human ovarian cancer cell lines SKOV3 (ATCC® HTB-77™) and Caov-3 (ATCC® HTB-75™) were purchased from the American Type Culture Collection (Rockville, MD, USA). A2780 (ECACC 93112519) was obtained from the European Collection of Authenticated Cell Cultures. Patricia Donahoe (Massachusetts General Hospital, Boston, MA, USA) provided the human IGROV-1, OVCAR5, and OVCAR8 ovarian cancer cell lines, which have been authenticated and are free of mycoplasma contamination as verified by the MycoAlert Mycoplasma Detection Kit from Cambrex (Rockland, ME, USA). All these cell lines were maintained in RPMI 1640 (GE Healthcare Life Sciences, Logan, UT, USA) medium supplemented with 10% FBS (MilliporeSigma, Burlington, MA, USA) and 1% penicillin/streptomycin (Thermo Fisher Scientific, Waltham, MA, USA) in a humidified incubator containing 5% CO2 at 37°C. The cells were resuspended with 0.05% trypsin-EDTA (Life Technologies Corporation, Grand Island, NY, USA) before subculturing.
+ Open protocol
+ Expand
10

Establishment and characterization of cell lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
After obtaining written informed consent, cell lines were established in our laboratory. The MTC-SK cell line (1 (link)) was derived from lymph node metastasis of a 51-year-old central European woman. MTC-SK cells grow as multicellular spheroids in suspension and were maintained in Ham's F12 medium (Biowhittaker, Verviers, Belgium), supplemented with 10% fetal bovine serum (FBS; PAA Laboratories GmbH, Pasching, Austria). HF-SAR fibroblasts (22 (link)) were established from normal skin of a 3-year old male child, cultured in Eagle's minimal essential medium (PAA Laboratories GmbH), supplemented with 10% FBS, in which the cells grew adherently. The cell lines were incubated without antibiotics at 37°C, 5% CO2 and 95% humidity and were Mycoplasma-free, confirmed with a MycoAlert®Mycoplasma Detection kit (Cambrex Bioscience, Rockland, ME, USA) and Hoechst 33258 (Sigma-Aldrich, Vienna, Austria). Hoechst stain (50 μl) was added to 50 μl cell suspension at a density of 2×105 (MTC-SK) and 1×105 (HF-SAR) cells/ml and incubated at room temperature for 5 min. The study was approved by the ethics committee of the Medical University of Graz, Austria (18–182 ex 06/07).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!